ArticleGynecologic oncology reports2021

Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?

Varun Khetan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.